Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

ALLISON PERKINS

Allopathic & Osteopathic Physicians Internal Medicine Pulmonary Disease

NPI
1083896047
CMS profile
94077
Location
PENSACOLA, FL

General Payments · PY2018–2024

$13,937.31

  • Reported across 66 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,329.59

14 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Acerta Pharma LLC $649.01 5
INTUITIVE SURGICAL, INC. $609.93 5
GlaxoSmithKline, LLC. $33.82 2
Janssen Pharmaceuticals, Inc $18.68 1
BOSTON SCIENTIFIC CORPORATION $18.15 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $196.06 5
PY2019 $1,489.17 5
PY2020 $59.55 1
PY2022 $75.75 5
PY2023 $10,787.19 36
PY2024 $1,329.59 14

Payment records · PY2024 (14)

Sorted by paying entity, then date · as published by CMS

Program year 2024 20182019202020222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AstraZeneca Pharmaceuticals LP $600.00 02/01/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1105503700 CMS
AstraZeneca Pharmaceuticals LP $17.99 10/02/2024 Food and Beverage Undisputed 01/23/2026 1105647090 CMS
AstraZeneca Pharmaceuticals LP $1.53 11/06/2024 Food and Beverage Undisputed 01/23/2026 1104371077 CMS
AstraZeneca Pharmaceuticals LP $13.85 11/06/2024 Food and Beverage Undisputed 01/23/2026 1105456954 CMS
AstraZeneca Pharmaceuticals LP $15.64 11/21/2024 Food and Beverage Undisputed 01/23/2026 1104577932 CMS
Boston Scientific Corporation $18.15 10/02/2024 Food and Beverage Undisputed 01/23/2026 1092414444 CMS
GlaxoSmithKline, LLC. $15.85 10/30/2024 Food and Beverage Undisputed 01/23/2026 1116589967 CMS
GlaxoSmithKline, LLC. $17.97 12/05/2024 Food and Beverage Undisputed 01/23/2026 1116231277 CMS
INTUITIVE SURGICAL, INC. $303.75 01/08/2024 Education Undisputed 01/23/2026 1137134795 CMS
INTUITIVE SURGICAL, INC. $6.00 09/16/2024 Travel and Lodging Undisputed 01/23/2026 1137262051 CMS
INTUITIVE SURGICAL, INC. $250.10 09/21/2024 Travel and Lodging Undisputed 01/23/2026 1137204943 CMS
INTUITIVE SURGICAL, INC. $37.94 10/01/2024 Food and Beverage Undisputed 01/23/2026 1137111237 CMS
INTUITIVE SURGICAL, INC. $12.14 10/01/2024 Food and Beverage Undisputed 01/23/2026 1137150132 CMS
Janssen Pharmaceuticals, Inc $18.68 12/10/2024 Food and Beverage Undisputed 01/23/2026 1077975218 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.